Vistry’s shares fell 3.4% after results, with the review exposing weaker execution than planned and prompting a reset toward lower volume and a more capital-light model. The shift to prioritizing cash conversion and returns over volume, alongside a medium-term target of 12,000 units, is the clearest sign investors may be concerned about the business’s growth and execution outlook.